Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...

Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, is reporting that all primary and secondary outcome measures were met in its Phase 4, multicenter study assessing the...

Today, Mitsubishi Aircraft Corporation officially announced its Mitsubishi SpaceJet family of aircraft. SpaceJet is the commercial name for the product family that includes the SpaceJet M90...

SONIFI Solutions, introduced SORA, its next generation interactive platform for hospitality. SORA is designed for the ever-evolving hospitality industry – empowering hoteliers with smart...

Treasure Investments Corporation dba Foundry Michelangelo prepare as The MoneyShow Seattle is rapidly approaching. This year's conference will include over 50 investor-specific sessions covering...

MetricNet is pleased to announce that Jeff Rumburg, Managing Partner of MetricNet, has been invited to present the industry's first ROI workshop at the annual Service Management World conference...

As part of its drive to create a significant and sustained impact on the world's environment, DocuSign (NADSAQ: DOCU) today announced a new commitment to The Wilderness Society, the leading...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new results from the Phase 3 clinical trials SELECT-EARLY and SELECT-COMPARE showing that patients receiving...

In a heavily regulated industry producing the most transparent financial metrics of any sector, why does the opinion of a single, privately-held insurer rating agency carry disproportionate...